Mobile HIV and Addiction Care for People Who Inject Drugs Reduces All-Cause Deaths by 71% in Five U.S. Cities (HPTN 094)
HPTN 094 Study Examines a Novel Way to Take Addiction Care and HIV Prevention to People Who Inject Drugs
HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention
Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains